Accredited Investors’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Sell
2,325
-732
-24% -$145K 0.02% 181
2026
Q1
$503K Sell
3,057
-242
-7% -$41.9K 0.03% 156
2025
Q4
$586K Buy
3,299
+448
+16% +$74.7K 0.03% 148
2025
Q3
$453K Buy
2,851
+453
+19% +$66.9K 0.03% 154
2025
Q2
$338K Buy
2,398
+4
+0.2% +$491 0.02% 180
2025
Q1
$279K Buy
2,394
+19
+0.8% +$2.45K 0.02% 181
2024
Q4
$299K Sell
2,375
-214
-8% -$26.4K 0.02% 179
2024
Q3
$270K Buy
2,589
+6
+0.2% +$604 0.02% 187
2024
Q2
$251K Sell
2,583
-172
-6% -$16.4K 0.02% 185
2024
Q1
$259K Sell
2,755
-640
-19% -$56.4K 0.02% 177
2023
Q4
$317K Sell
3,395
-90
-3% -$7.2K 0.02% 149
2023
Q3
$285K Buy
+3,485
New +$303K 0.02% 145

Other funds holding MS

Accredited Investors's MS Position: Q2 2026 in Review

Accredited Investors reduced its Morgan Stanley (MS) stake by 24% in Q2 2026, selling an estimated $145K and leaving 2,325 shares worth $486K. The position accounts for 0.02% of the portfolio, ranked #181.

Accredited Investors first reported a position in MS in Q3 2023 and has held it in 12 quarters since. The position peaked at $586K in Q4 2025. 2,725 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Accredited Investors held 2,325 shares of Morgan Stanley worth $486K as of Q2 2026.
  • Accredited Investors sold 732 Morgan Stanley shares in Q2 2026, an estimated $145K.
  • Morgan Stanley made up 0.02% of Accredited Investors's portfolio in Q2 2026, its #181 holding.
  • Accredited Investors first reported a position in Morgan Stanley in Q3 2023 and has held it in 12 quarters since.
  • Accredited Investors's Morgan Stanley position peaked at $586K in Q4 2025.
  • 2,725 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.